Cabaletta Bio (CABA) Net Cash Flow (2018 - 2025)

Cabaletta Bio has reported Net Cash Flow for 8 years, with the latest figure at $22.8 million in Q4 2025.

• For the quarter ending Q4 2025, Net Cash Flow rose 443.86% year-over-year to $22.8 million; the trailing twelve-month figure through Dec 2025 stood at -$81.0 million (down 176.86% YoY), and the FY2025 full-year result was -$81.0 million, down 176.86% from the prior year.
• Net Cash Flow for Q4 2025 stood at $22.8 million, up from -$85.4 million in the prior quarter.
• The five-year high for Net Cash Flow was $77.7 million in Q4 2023, with the low at -$85.4 million in Q3 2025.
• Average Net Cash Flow over 5 years is -$922300.0, with a median of $2.8 million recorded in 2021.
• Year-over-year, Net Cash Flow soared 649.01% in 2021 and slumped 1409.37% in 2022.
• Tracing CABA's Net Cash Flow over 5 years: stood at $4.0 million in 2021, then jumped by 416.0% to $20.4 million in 2022, then soared by 280.24% to $77.7 million in 2023, then tumbled by 108.52% to -$6.6 million in 2024, then soared by 443.86% to $22.8 million in 2025.
• The last three Net Cash Flow figures came in at $22.8 million (Q4 2025), -$85.4 million (Q3 2025), and $13.8 million (Q2 2025), per Business Quant data.

Peer Comparison